---
title: Ketorolac
notetype: feed
feed: show
date: 18-06-2024
tags: Drug, clerkship 
author: Jasleen, Dragoman
---
## What is Ketorolac?
- Nonsteroidal anti-inflammatory drug used primarily for short term, acute pain management.

## Mechanism of Action [^1]
- COX-1 and COX-2 inhibitor
	- COX-1: involved in platelet aggregation, gastric mucosa, vascular endothelium
	- COX-2: converts arachadonic acid -> prostaglandins -> inflammation. Inhibition provides analgesic and anti-inflmmatory properties.
- Rapidly absorbed after oral administration. Binds to plasma proteins and is metabolized in the liver. Metabolites excreted mainly by the kidney.
- Half-life: 5-6 hours.

## Dosage
- 15 - 30 mg PO/IV every 6 hours. Ceiling effect exists above 15 mg.
- Pediatrics 0.5 mg/kg PO/IV every 6 hours

## Indications 
- Analgesia (see [[Pain Management|Pain Management]])

## Contraindications [^3]
- Renal insufficiency
- Pregnancy (risks premature ductus arteriosus)
- Bleeding disorders
- Surgical concerns of bone, wound or anastomosis
- peptic ulcer

## References
[^1]: Mahmoodi, N., Patel, P., Kim, P. (2024, February 28). *Ketorolac*. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK545172/ 
[^2]: Shafer SL, Rathmell JP, Flood P. Stoeltingâ€™s pharmacology and physiology in anesthetic practice. Fifth edition. Philadelphia: Wolters Kluwer Health; 2015. 900 p.[^3]: Birdi T, Sullivan P. Ottawa anesthesia primer. Toronto, Ontario: Echo Book Publishing; 2012.




